Moderate to Severe Persistent Asthma
1 clinical trials · Condition
◉ Watch Moderate to Severe Persistent Asthma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation (NCT04773678) | Connect Biopharm LLC | 2021-05-11 |
Track Moderate to Severe Persistent Asthma automatically
Every clearance here is in the API, with alerts when new ones post.